We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immunology

Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

A companion diagnostic now enables selection of patients with esophageal or GEJ carcinoma for pembrolizumab based on tumor PD-L1 expression. More...
30 Mar 2026
Image: The findings indicate common blood tests can provide insight to tumor activity before treatment begins (photo courtesy of Adobe Stock)

Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer

A new study shows that systemic inflammatory signals can offer insight into tumor activity in bladder cancer. More...
26 Mar 2026
Image: Overview of the microfluidic assay for cancer-associated leukocyte adhesion profiling (Photo courtesy of Brian Choi, Seyong Kwon, Min Seok Lee, et al.,)

Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals

A new microfluidic technology uses immune cell behavior to detect cancer recurrence and monitor treatment response.

More...
24 Mar 2026
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Five mutation patterns in cancer proteins may influence immunotherapy response. More...
06 Mar 2026
Image: The study identified a distinct immune signature associated with treatment-resistant myasthenia gravis (Dodd, Katherine C. et al., Med (2026). DOI: 10.1016/j.medj.2025.100987)

Immune Signature Identified in Treatment-Resistant Myasthenia Gravis

Researchers have found a distinct immune signature linked to treatment resistance in myasthenia gravis. More...
03 Mar 2026
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

A new AI biomarker improves chemotherapy prediction in triple-negative breast cancer. More...
19 Feb 2026
Image: A cryo-electron tomography slice (left) of human T-cell leukemia virus particles (Photo courtesy of William Arndt/UM School of Dentistry and Masonic Cancer Center)

High-Resolution Cancer Virus Imaging Uncovers Potential Therapeutic Targets

High-resolution imaging reveals the detailed 3D structure of the HTLV capsid protein, guiding drug development. More...
17 Feb 2026
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group


The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.
Copyright © 2000-2026 Globetech Media. All rights reserved.